About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Philadelphia | 631 Studies

Clinical Trials Breast CancerPhiladelphia

Breast Cancer Clinical Trials in Philadelphia

Find 631 clinical trials for breast cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 631 trials

CompletedPrinted Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerRATIONALE: Printed educational materials, such as the Facing Forward Series: Life After Cancer Treatment manual, may help make the transition from cancer patient to cancer…NCT00372840·Philadelphia, Pennsylvania RecruitingSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of…NCT06393374·Mobile, Alabama and 310 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedRisk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or TrastuzumabInvestigators will evaluate the safety, tolerability, and feasibility of a risk-guided cardioprotective treatment strategy with carvedilol, as compared to usual care, in breast…NCT04023110·Philadelphia, Pennsylvania

RecruitingQuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerThis study will assess whether a quantitative, HER2 assay can accurately and reliably discriminate between responders and non-responders among patients with HER2 IHCI+ metastatic…NCT06551116·San Francisco, California and 36 others

CompletedPilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)This is a phase I study to evaluate the safety and define the pharmacokinetic (PK) profile of orally administered reparixin in combination with paclitaxel in HER 2 (Human…NCT02001974·Scottsdale, Arizona and 4 others

CompletedStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerThis study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast cancer, and associated health…NCT05498155·Loveland, Colorado and 35 others

TerminatedImaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast CancerPilot study using \[18F\]ISO-1 PET/CT to image sigma-2 receptor binding in metastatic breast cancer.NCT03057743·Philadelphia, Pennsylvania

RecruitingTargeted Palliative Care Intervention for Patients With Metastatic Breast CancerMany people living with metastatic breast cancer face challenging symptoms and frequent medical visits.NCT06795529·Boston, Massachusetts and 2 others

CompletedA Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and…NCT03752398·San Diego, California and 17 others

CompletedPilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital MammographyThe purpose of this pilot study is to provide credible performance estimate information in order to properly plan, design, and power a larger clinical study.NCT01928992·Philadelphia, Pennsylvania

CompletedA Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerThis study is designed to evaluate the efficacy, safety, and pharmacokinetics of several immunotherapy-based combination treatments in participants with inoperable locally…NCT03280563·Birmingham, Alabama and 21 others

CompletedA Cost-Effective Handheld Breast Scanner for Use in Low Resource Environments: A Validation StudyValidation of the PEFS to detect breast tumors will be performed by means of a prospective trial. Subjects will participate for 1 clinic visit.NCT02814292·Philadelphia, Pennsylvania

CompletedEvaluation of GLR2007 for Advanced Solid TumorsEvaluation of GLR2007 for Advanced Solid TumorsNCT04444427·Lafayette, Indiana and 3 others

CompletedGenetic Counseling in African American WomenThe objectives of this study are to develop a Culturally Tailored Genetic (CTGC) protocol for African American women and evaluate its impact on decision making and satisfaction…NCT00419510·Philadelphia, Pennsylvania

CompletedDC Vaccine for Patients With Ductal Carcinoma In SituWomen who are diagnosed with Her-2/neu over-expressing DCIS will receive DC1 vaccines by intranodal, intralesional, or both routes of administration.NCT02061332·Philadelphia, Pennsylvania

CompletedAnastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyRATIONALE: Estrogen can stimulate the growth of breast cancer cells. Tamoxifen may fight breast cancer by blocking the use of estrogen.NCT00053898·Anniston, Alabama and 739 others

CompletedA Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive CancersThis study is an open-label Phase 1 trial of MM-111.NCT00911898·Los Angeles, California and 3 others

RecruitingAvelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerThis clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are…NCT04841148·Washington D.C., District of Columbia and 6 others

Active not recruitingA Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)This is a Phase III, randomized, open-label, 3-arm, multicenter, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with ICT in…NCT05629585·Gilbert, Arizona and 275 others

CompletedStudy to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerTo compare the combination of Ribociclib plus goserelin acetate with hormonal therapy versus combination chemotherapy in premenopausal or perimenopausal patients with advanced or…NCT03839823·Cairo and 49 others

PreviousPage 7 of 32Next

Other Conditions in Philadelphia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma